Michael Morgan
Northern Arizona University(US)Arena Pharmaceuticals (United States)(US)Centra Health(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Diabetes Treatment and Management, Pharmacology and Obesity Treatment, Neuropeptides and Animal Physiology
Most-Cited Works
- → Biodegradable block copolymers for delivery of proteins and water-insoluble drugs(2001)580 cited
- → Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization(2008)401 cited
- → Comparison of self-report, video observation and direct measurement methods for upper extremity musculoskeletal disorder physical risk factors(2001)343 cited
- → Myosin light-chain phosphatase(1976)249 cited
- → Discovery and Structure−Activity Relationship of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a Selective Serotonin 5-HT2C Receptor Agonist for the Treatment of Obesity(2007)200 cited
- → The long-term effects of multiple doses of methamphetamine on neostriatal trypthophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities